| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000038010 |
| Receipt No. | R000043225 |
| Scientific Title | Cognitive behavioral therapy for chronic pain in Japan: a randomized controlled trial |
| Date of disclosure of the study information | 2019/10/01 |
| Last modified on | 2020/12/21 (Ver. 5) |
| Basic information | ||
| Public title | Cognitive behavioral therapy for chronic pain in Japan: a randomized controlled trial | |
| Acronym | Cognitive behavioral therapy for chronic pain in Japan: a randomized controlled trial | |
| Scientific Title | Cognitive behavioral therapy for chronic pain in Japan: a randomized controlled trial | |
| Scientific Title:Acronym | Cognitive behavioral therapy for chronic pain in Japan: a randomized controlled trial | |
| Region |
|
|
| Condition | |||
| Condition | Chronic Pain | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | This study compares the treatment efficacy of individualized cognitive behavioral therapy for chronic pain (CBT-CP) with Treatment-As-Usual (TAU) among Japanese chronic pain patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | 1) The change of EuroQol five-dimensional questionnaire five level (EQ5D-5L)
(Evaluations are performed at baseline and at 15 +/- 2 weeks after baseline assessment using self-administered questionnaires.) |
| Key secondary outcomes | 2) Medical Outcomes in the 12-Item Short Form Health Survey (SF-12)
3) Numerical Rating Scale (NRS) 4) Pain Disability Assessment Scale (PDAS) 5) Patient Health Questionnaire-9 (PHQ-9) 6) Pain Catastrophizing Scale (PCS) 7) Tampa Scale for Kinesiophobia eleven (TSK-11) 8) Pain Self-Efficacy Questionnaire (PSEQ) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | CBT-CP with TAU: CBT-CP in this study is a structured and manualized eight-session program consisting of psychoeducation, relaxation, activity pacing, cognitive reconstruction, and relapse prevention, supported with the use of a workbook and a worksheet. During this treatment period, the participants continue receiving TAU. | |
| Interventions/Control_2 | Waitlist control with TAU: although waitlist participants will not receive CBT-CP during the 15-week waitlist period, they will receive it following the period. While on the waitlist, participants will continue receiving TAU. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Chronic pain that has persisted for at least 3 months
2) EQ5D-5L <= 0.80 3) Disability due to chronic pain 4) Age 20-80 years 5) Understanding of the study and signing the consent document of own free will |
|||
| Key exclusion criteria | 1) Receiving other psychotherapy or clinical trial
2) Having previously received CBT to treat chronic pain 3) Schedule to receive medical examination or treatment that may interfere with participation in or results of the study 4) Organic causes of pain requiring immediate medical attention 5) Chronic pain mainly consisting of headache 6) Chronic pain due to surgery or external injury 7) Receipt of compensation or beneficiary of successful lawsuit related to chronic pain 8) Alcohol or substance use disorder 9) Manic episodes or diagnosis of any psychotic disorder 10) Severe suicidal ideation 11) Unable to perform cognitive functions required by CBT 12) Inability or poor ability to communicate, read, or write in Japanese 13) Pregnancy 14) Unsuitability for any other reason, as judged by the attending physician |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kansai University | ||||||
| Division name | Faculty of Sociology | ||||||
| Zip code | 564-8680 | ||||||
| Address | 3-3-35, Yamate-cho, Suita-shi, Osaka, 564-8680, Japan | ||||||
| TEL | 06-6368-1973 | ||||||
| hosogosh@kansai-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kansai University | ||||||
| Division name | Faculty of Sociology | ||||||
| Zip code | 564-8680 | ||||||
| Address | 3-3-35, Yamate-cho, Suita-shi, Osaka, 564-8680, Japan | ||||||
| TEL | 06-6368-1973 | ||||||
| Homepage URL | https://jacc-pain.wixsite.com/sanka | ||||||
| hosogosh@kansai-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kansai University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Ministry of Education, Culture, Sports, Science and Technology (MEXT). Japan Society for the Promotion of Science (JSPS). Grant-in-Aid for Scientific Research (B). |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board, Graduate School of Psychology, Kansai University |
| Address | 3-3-35, Yamate-cho, Suita-shi, Osaka, 564-8680, Japan |
| Tel | 06-6368-1121 |
| pcp@ml.kandai.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | Senriyama Hospital (Osaka), National Center of Neurology and Psychiatry Hospital (Tokyo), Kawasaki Medical School Hospital (Okayama), Kobe University Hospital (Hyogo), Jikei University Hospital (Tokyo) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 6 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043225 |